The consultancy GENESIS Biomed, a member of CATALONIA.HEALTH, held its 2025 Annual Symposium at the Auditori Antoni Caparrós of the Barcelona Science Park, which brought together more than 110 professionals from the local and national ecosystem, from public entities and private companies.
Josep Lluís Falcó, founder and CEO of GENESIS Biomed, addressed the main trends in healthcare entrepreneurship and the challenges facing the sector in Spain. Among the topics highlighted were the impact of the EU Artificial Intelligence Regulation (EU 2024/1689), and the role of the European Health Data Space (EHDS) as a decentralised network to improve access to data in research and personalised medicine. The evolution of “X-as-a-Service” business models and the Gain Sharing model as the latest trend of market access based on value and savings at a systemic level were also discussed. In addition, the bottom-up approach was presented as a strategy for scaling technologies from hospitals to national health systems.
In addition, it was also presented the success story of Corify Care, a spin-off of the Fundación de Investigación Biomédica del Hospital General Universitario Gregorio Marañón and of the Universidad Politécnica de Valencia, led by Andreu M. Climent, which has developed the fastest and most global non-invasive cardiac mapping system on the market, doubling the success rate in complex arrhythmia ablations.
Moreover, a round table was also held focused on the current state of innovation in health in the national ecosystem, which brought together leading personalities from the sector, such as Ana Isabel González (Ministry of Health), Manuel Desco (Instituto de Investigación Sanitaria Gregorio Marañón), Alberto Bermejo (Clave Capital) and Izabel Alfany (EIT Health Spain), who was also joined by Andreu M. Climent himself. Among the topics discussed were the secondary use of data in health, the regulatory challenges for spin-offs and start-ups, the burdensome cost of patents for spin-offs/start-ups, and the importance of public-private collaboration to promote advanced therapies.
Josep Lluís Falcó, founder and CEO of GENESIS Biomed, said: “this conference has served as a space for debate and exchange of ideas to find answers and proposals that contribute to strengthening healthcare entrepreneurship, innovation and the growth of the biomedicine ecosystem”.
Comments